A28513K Stock Overview
Provides chemicals and life sciences products and solutions in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
SK Chemicals Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩19,780.00 |
| 52 Week High | ₩32,450.00 |
| 52 Week Low | ₩19,350.00 |
| Beta | 0.90 |
| 11 Month Change | -14.74% |
| 3 Month Change | -17.41% |
| 1 Year Change | -33.06% |
| 33 Year Change | -76.59% |
| 5 Year Change | -3.04% |
| Change since IPO | -35.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| A28513K | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | 0.5% | 0.3% | 2.4% |
| 1Y | -33.1% | -35.0% | -4.0% |
Return vs Industry: A28513K exceeded the KR Chemicals industry which returned -35% over the past year.
Return vs Market: A28513K underperformed the KR Market which returned -4% over the past year.
Price Volatility
| A28513K volatility | |
|---|---|
| A28513K Average Weekly Movement | 2.3% |
| Chemicals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A28513K has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A28513K's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | 1,345 | JAEHYEON AHN | www.skchemicals.com |
SK Chemicals Co.,Ltd provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis.
SK Chemicals Co.,Ltd Fundamentals Summary
| A28513K fundamental statistics | |
|---|---|
| Market cap | ₩777.09b |
| Earnings (TTM) | ₩35.20b |
| Revenue (TTM) | ₩1.81t |
23.4x
P/E Ratio0.5x
P/S RatioIs A28513K overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A28513K income statement (TTM) | |
|---|---|
| Revenue | ₩1.81t |
| Cost of Revenue | ₩1.32t |
| Gross Profit | ₩483.44b |
| Other Expenses | ₩448.24b |
| Earnings | ₩35.20b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.83k |
| Gross Margin | 26.74% |
| Net Profit Margin | 1.95% |
| Debt/Equity Ratio | 56.2% |
How did A28513K perform over the long term?
See historical performance and comparison